North of England evidence based guideline development project: guideline on the use of aspirin as secondary prophylaxis for vascular disease in primary care. North of England Aspirin Guideline Development Group.
Eccles
M
M
Centre for Health Services Research, University of Newcastle upon Tyne, Newcastle upon Tyne NE2 4AA. Martin.Eccles@ncl.ac.uk
Freemantle
N
N
Mason
J
J
D000787:Angina Pectoris / Q000517:prevention & control; D001241:Aspirin / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000517:prevention & control*; D002561:Cerebrovascular Disorders / Q000517:prevention & control; D003257:Consumer Product Safety; D003362:Cost-Benefit Analysis; D003920:Diabetes Mellitus / Q000517:prevention & control; D004334:Drug Administration Schedule; D016527:Drug Costs; D006801:Humans; D007383:Intermittent Claudication / Q000517:prevention & control; D002546:Ischemic Attack, Transient / Q000517:prevention & control; D009203:Myocardial Infarction / Q000517:prevention & control; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D014652:Vascular Diseases / Q000517:prevention & control
D010975:Platelet Aggregation Inhibitors; D001241:Aspirin